MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Pesticide Exposure and Parkinson’s Disease Motor Subtype

    D. Thordarson, J. Bronstein, A. Keener, B. Ritz, K. Paul (Los Angeles, USA)

    Objective: The present study aims to investigate the link between Parkinson’s disease (PD) motor subtype and PD-relevant pesticide exposures. Background: PD is a neurodegenerative disorder…
  • 2025 International Congress

    Clinical Characteristics of Parkinsons Disease and their Role in Differential Diagnosis

    M. Ganieva, L. Tolibova (Dushanbe, Tajikistan)

    Objective: To study and systematize the clinical characteristics of Parkinson's disease (PD) and their role in differential diagnosis with other parkinsonian syndromes. Background: Parkinson’s disease…
  • 2025 International Congress

    A Biomarker-Directed Approach to the Early Diagnosis of Parkinson’s Disease Using Artificial Intelligence and Machine Learning

    ME. Mellaci (SÃO PAULO, Brazil)

    Objective: The main purpose of this study was to assess how AI and ML methods integrate multiple biomarkers for diagnosing Parkinson’s Disease (PD) to improve…
  • 2025 International Congress

    Establishing a Timeline of Non-Motor and Motor Symptoms Progression in Parkinson’s Disease Using a Sub-Chronic MPTP Mouse Model

    M. Chopra, A. Sekar, R. Hussain, L. Diwakar (Bengaluru, India)

    Objective: Parkinson’s disease (PD) mouse model using 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was explored for pathological mechanisms driving non-motor symptoms (NMS). Aim was to map the behavioural changes…
  • 2025 International Congress

    Unveiling the Molecular Mechanism of Polydatin in Ameliorating Parkinson’s Disease via the DRD2/CRYAB/NF-κB Axis in Astrocytes and Exploring Cell Therapy Strategies

    SJ. Peng, LP. Wang, YJ. Ou, RE. Liu (Beijing, China)

    Objective: Define polydatin's therapeutic mechanism targeting astrocyte-mediated neuroinflammation in Parkinson's disease (PD) and assess combinatorial efficacy with dopamine progenitor transplantation. Background: PD progression involves substantia…
  • 2025 International Congress

    Neural Correlates of Rhythmic Auditory Stimulation Responsiveness in Parkinson’s Disease: A Pilot Gait and fMRI Study

    CY. Chien, CL. Lin, JSK. Chang, YH. Liu, SC. Wang, CC. Lin (Tainan, Taiwan)

    Objective: To compare neural activity differences between Parkinson's disease patients responsive to rhythmic auditory stimulation (RAS-r) and those not responsive (RAS-n) using functional MRI (fMRI).…
  • 2025 International Congress

    Levodopa mediated normalization of cerebello-thalamo-cortical GABA and Glutamate in Parkinson’s disease

    S. Prasad, D. Deelchand, M. Kumar, R. Yadav, P. Pal, J. Saini (Bengaluru, India)

    Objective: This study aims to evaluate the effect of levodopa on cerebello-thalamo-cortical (CTC) gamma-aminobutyric acid (GABA) and glutamate in patients with Parkinson’s disease (PD) using…
  • 2025 International Congress

    Exploring the Association between Autonomic Responses and Dopaminergic Pathways in Early Parkinson’s Disease

    E. Garasto, A. Stefani, M. Pierantozzi, N. Mercuri, A. Chiaravalloti, C. Rocchi (Rome, Italy)

    Objective: To assess if cardiovascular dysautonomia, evaluated by autonomic function tests (AFTs), is related to dopaminergic nicgrostriatal loss and other non-motor symptoms in early Parkinson…
  • 2025 International Congress

    Genetic Correlations Between Parkinson’s Disease and Circulating Metabolites

    M. Tan, T. Ascencio, S. Rodriguez-Quiroga, J. Largo González, S. Peña Martinez, L. Hernandez Delgado, A. Noyce (San Salvador, El Salvador)

    Objective: To use genome-wide association studies (GWASs) to identify genetic correlations between Parkinson’s disease (PD) and circulating metabolites. Background: Metabolomics is the study of small…
  • 2025 International Congress

    Deep phenotyping of Parkinson‘s disease patients with the RAB32 Ser71Arg pathogenic variant and MDSGene literature review

    T. Kleinz, F. Cavallieri, M. Borsche, G. Toschi, F. Valzania, EM. Valente, P. Mitrotti, M. Avenali, S. Zittel, R. Born, M. Matarazzo, C. Shambetova, N. Griebner, L. Santinelli, M. Brand, C. Gabbert, A. Westenberger, J. Trinh, M. Radefeldt, C. Beetz, P. Bauer, N. Brüggemann, C. Klein (Reggio Emilia, Italy)

    Objective: To evaluate patients with PD and unaffected carriers of the pathogenic variant RAB32 p.Ser71Arg using a multimodal approach to gain insight into genotype-phenotype relationships…
  • « Previous Page
  • 1
  • …
  • 206
  • 207
  • 208
  • 209
  • 210
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley